Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
European Heart Journal|January 17, 2023
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk scoreMaria A de Winter, Harry R Büller, Marc Carrier, et al.
European Journal of Preventive Cardiology|April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM modelMarga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
European Journal of Preventive Cardiology|October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease preventionSteven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Diabetes, Obesity & Metabolism|March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D modelMarga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
International Journal of Cardiology|September 7, 2024
Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohortJoshua A N van Apeldoorn, Steven H J Hageman, Ralf E Harskamp, et al.
European Heart Journal|May 19, 2019
Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy peopleNicole E M Jaspers, Michael J Blaha, Kunihiro Matsushita, et al.
European Heart Journal|January 11, 2019
Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitusGijs F N Berkelmans, Soffia Gudbjörnsdottir, Frank L J Visseren, et al.
European Journal of Preventive Cardiology|June 2, 2023
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2Steven H J Hageman, Carmen Petitjaen, Lisa Pennells, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
Pageof 7